Two Seas Capital LP
13F filer · CIK 0001823138Reported Aug 12, 2026
Net seller this quarter
13F portfolio value$5.05BU.S. long equity reported on 13F
Positions376 new · 3 closed
Net flow last quarter-$97.4MBuys minus sells
Top 10 positions weight35.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 12, 202637 positions | |||||
| $300M | 5.94% | 1.17% | -9.1% | Q4 2021 | |
| $238M | 4.72% | 7.54% | +11.1% | Q3 2024 | |
| $231M | 4.58% | 2.83% | -44.1% | Q1 2024 | |
| $216M | 4.28% | 15.17% | +57.8% | Q4 2025 | |
| $195M | 3.86% | 1.06% | -12.4% | Q2 2024 | |
| $143M | 2.83% | 2.85% | -26.7% | Q2 2023 | |
| $121M | 2.40% | 1.53% | -1.7% | Q3 2023 | |
| $120M | 2.38% | 9.58% | +0.2% | Q4 2024 | |
| $110M | 2.17% | Not reported | +210.5% | Q1 2026 | |
| $104M | 2.05% | 2.05% | -3.1% | Q1 2024 | |
| $91.7M | 1.82% | 9.66% | +2.9% | Q4 2021 | |
| $68.3M | 1.35% | 0.13% | +132.0% | Q1 2024 | |
| $67.4M | 1.33% | 0.24% | -2.6% | Q1 2025 | |
| $66.4M | 1.31% | 2.08% | +10.9% | Q1 2026 | |
| $61.6M | 1.22% | 0.50% | -38.0% | Q2 2024 | |
| $60.9M | 1.21% | 1.21% | -4.2% | Q1 2025 | |
| $51.1M | 1.01% | 1.05% | +31.6% | Q3 2025 | |
| $50M | 0.99% | 0.49% | -0.5% | Q2 2025 | |
| $35.7M | 0.71% | Not reported | New | Q2 2026 | |
| $32.6M | 0.65% | 0.31% | New | Q2 2026 | |
| $30.5M | 0.60% | 2.14% | +2.6% | Q1 2026 | |
| $30.2M | 0.60% | 0.12% | -57.8% | Q2 2025 | |
| $28.2M | 0.56% | 0.33% | +3025.4% | Q1 2026 | |
| $27.4M | 0.54% | 6.32% | New | Q2 2026 | |
| SOSOCSable Offshore Corp. | $25.8M | 0.51% | 5.42% | +52.4% | Q4 2024 |
| $23.8M | 0.47% | 0.64% | -32.6% | Q4 2024 | |
| $18.4M | 0.36% | Not reported | New | Q2 2026 | |
| $18.2M | 0.36% | 0.13% | -36.8% | Q3 2024 | |
| $15.2M | 0.30% | Not reported | Not reported | Q3 2025 | |
| $9.61M | 0.19% | 0.60% | -22.7% | Q4 2021 | |
| $6.42M | 0.13% | 3.15% | +100.0% | Q3 2025 | |
| $6.4M | 0.13% | 0.04% | Not reported | Q3 2024 | |
| $5.44M | 0.11% | Not reported | Not reported | Q1 2024 | |
| $4.76M | 0.09% | 9.53% | Not reported | Q4 2021 | |
| $3.23M | 0.06% | 0.06% | +1298.9% | Q1 2026 | |
| $2.74M | 0.05% | 7.36% | Not reported | Q1 2026 | |
| $601K | 0.01% | Not reported | Not reported | Q1 2024 | |
| Q1 2026Reported May 15, 202634 positions | |||||
| $258M | 3.61% | 1.30% | -4.7% | Q4 2021 | |
| $242M | 3.38% | 5.10% | -5.1% | Q1 2024 | |
| $214M | 2.99% | 6.85% | -14.6% | Q3 2024 | |
| $185M | 2.58% | 1.28% | +47.8% | Q2 2024 | |
| $145M | 2.02% | 3.80% | -7.1% | Q2 2023 | |
| $141M | 1.97% | 9.61% | +162.9% | Q4 2025 | |
| $99M | 1.38% | 9.57% | -3.5% | Q4 2024 | |
| SOSOCSable Offshore Corp. | $90.8M | 1.27% | 3.66% | +217.1% | Q4 2024 |
| $86.4M | 1.21% | 2.12% | +36.5% | Q1 2024 | |
| $83.5M | 1.17% | 9.42% | +47.4% | Q4 2021 | |
| $79.5M | 1.11% | 1.57% | +11.7% | Q3 2023 | |
| $69M | 0.96% | 1.26% | +8.9% | Q1 2025 | |
| $62.6M | 0.87% | 0.25% | +37.2% | Q1 2025 | |
| $59.8M | 0.84% | 0.28% | +6.6% | Q2 2025 | |
| $58.1M | 0.81% | 0.95% | -10.6% | Q2 2024 | |
| $44.7M | 0.63% | 0.80% | -5.0% | Q3 2025 | |
| ETESPREsperion Therapeutics, Inc. | $31.2M | 0.44% | 4.44% | -4.3% | Q2 2023 |
| $27.9M | 0.39% | 0.05% | -25.7% | Q1 2024 | |
| $26.4M | 0.37% | 0.51% | +570.5% | Q2 2025 | |
| $21.3M | 0.30% | 2.06% | New | Q1 2026 | |
| $20.9M | 0.29% | 0.54% | New | Q1 2026 | |
| $20.4M | 0.28% | 0.08% | -43.0% | Q1 2025 | |
| $19.4M | 0.27% | 2.09% | New | Q1 2026 | |
| $19.2M | 0.27% | 0.94% | Not reported | Q4 2024 | |
| $12.3M | 0.17% | 0.76% | +185.1% | Q4 2021 | |
| $11.7M | 0.16% | 0.22% | -49.1% | Q3 2024 | |
| $9.47M | 0.13% | Not reported | New | Q1 2026 | |
| $4.68M | 0.07% | 7.36% | New | Q1 2026 | |
| $4.66M | 0.07% | 9.58% | +7.9% | Q4 2021 | |
| $3.45M | 0.05% | 1.82% | Not reported | Q3 2025 | |
| $2.53M | 0.04% | Not reported | Not reported | Q1 2024 | |
| $1.02M | 0.01% | 0.01% | New | Q1 2026 | |
| $362K | 0.01% | Not reported | Not reported | Q1 2024 | |
| $147K | 0.00% | 0.00% | New | Q1 2026 | |
| Q4 2025Reported Feb 11, 202628 positions | |||||
| $248M | 5.10% | 5.41% | +10.7% | Q1 2024 | |
| $212M | 4.38% | 1.38% | -16.7% | Q4 2021 | |
| $183M | 3.78% | 4.09% | -51.4% | Q2 2023 | |
| $147M | 3.03% | 0.86% | +46.9% | Q2 2024 | |
| $139M | 2.86% | 8.04% | +21.3% | Q3 2024 | |
| $77.8M | 1.60% | 1.55% | +30.8% | Q1 2024 | |
| $74.9M | 1.54% | 9.89% | +2.6% | Q4 2024 | |
| $74.3M | 1.53% | 0.26% | -16.6% | Q2 2025 | |
| $72.9M | 1.50% | 1.41% | +3.8% | Q3 2023 | |
| $60.6M | 1.25% | 6.54% | +14.5% | Q4 2021 | |
| $51.7M | 1.07% | 1.07% | +16.9% | Q2 2024 | |
| ETESPREsperion Therapeutics, Inc. | $44M | 0.91% | 4.98% | +22.1% | Q2 2023 |
| $43.7M | 0.90% | 0.84% | +37.5% | Q3 2025 | |
| $43.6M | 0.90% | 1.16% | +6.8% | Q1 2025 | |
| $40.3M | 0.83% | 0.07% | +46.9% | Q1 2024 | |
| $36.7M | 0.76% | 0.18% | -30.9% | Q1 2025 | |
| $31.5M | 0.65% | 3.66% | New | Q4 2025 | |
| $28.8M | 0.59% | 0.14% | +46.9% | Q1 2025 | |
| $22.6M | 0.47% | 0.45% | Not reported | Q3 2024 | |
| SOSOCSable Offshore Corp. | $15.6M | 0.32% | 1.20% | +182.3% | Q4 2024 |
| $10.2M | 0.21% | 9.30% | +13.5% | Q4 2021 | |
| $9.42M | 0.19% | Not reported | -41.2% | Q4 2022 | |
| $7.88M | 0.16% | Not reported | -60.6% | Q3 2025 | |
| $5.66M | 0.12% | 0.27% | -39.3% | Q4 2021 | |
| $4.51M | 0.09% | 0.08% | -33.8% | Q2 2025 | |
| $3.27M | 0.07% | 2.29% | Not reported | Q3 2025 | |
| $2.45M | 0.05% | Not reported | Not reported | Q1 2024 | |
| $351K | 0.01% | Not reported | Not reported | Q1 2024 | |
| Q3 2025Reported Nov 14, 202531 positions | |||||
| $276M | 4.42% | 4.98% | +126.9% | Q1 2024 | |
| $253M | 4.07% | 8.42% | -7.9% | Q2 2023 | |
| $178M | 2.85% | 1.70% | +10.9% | Q4 2021 | |
| $114M | 1.82% | 0.58% | -11.2% | Q2 2024 | |
| $105M | 1.69% | 6.63% | +27.9% | Q3 2024 | |
| APAVDLAvadel Pharmaceuticals PLC | $82M | 1.32% | 5.52% | -12.8% | Q1 2024 |
| $75.1M | 1.21% | 0.32% | +3306.9% | Q2 2025 | |
| $58.6M | 0.94% | 9.64% | +26.3% | Q4 2024 | |
| $53.1M | 0.85% | 1.19% | -16.1% | Q1 2024 | |
| $49.9M | 0.80% | 5.73% | +5.3% | Q4 2021 | |
| $45M | 0.72% | 0.26% | +50.8% | Q1 2025 | |
| $44.5M | 0.71% | 1.58% | +22.6% | Q3 2023 | |
| $44.3M | 0.71% | 1.05% | +20.5% | Q1 2025 | |
| $44M | 0.71% | 0.88% | +68.4% | Q2 2024 | |
| $38.2M | 0.61% | Not reported | New | Q3 2025 | |
| $33.3M | 0.53% | 0.05% | -26.5% | Q1 2024 | |
| $26.3M | 0.42% | 0.10% | -6.2% | Q1 2025 | |
| ETESPREsperion Therapeutics, Inc. | $25.8M | 0.41% | 4.84% | -2.1% | Q2 2023 |
| $22.3M | 0.36% | 0.61% | New | Q3 2025 | |
| $19.2M | 0.31% | 0.73% | +1.6% | Q1 2023 | |
| $17.8M | 0.29% | Not reported | +61.1% | Q4 2022 | |
| SOSOCSable Offshore Corp. | $10.7M | 0.17% | 0.62% | +39.0% | Q4 2024 |
| $8.91M | 0.14% | 9.07% | +219.4% | Q4 2021 | |
| $8.39M | 0.13% | 0.44% | +89.0% | Q4 2021 | |
| $7.69M | 0.12% | 0.23% | Not reported | Q4 2024 | |
| $5.82M | 0.09% | 0.12% | +84.8% | Q2 2025 | |
| $3.37M | 0.05% | Not reported | -13.9% | Q1 2024 | |
| $3.03M | 0.05% | 2.18% | New | Q3 2025 | |
| $2.36M | 0.04% | 0.12% | New | Q3 2025 | |
| $1.18M | 0.02% | 35000.00% | New | Q3 2025 | |
| $432K | 0.01% | Not reported | Not reported | Q1 2024 | |
Premium opens every quarter this fund has filed